Literature DB >> 20139367

Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling.

Katharina Lötzer1, Sandra Döpping, Sabine Connert, Rolf Gräbner, Rainer Spanbroek, Birgit Lemser, Michael Beer, Markus Hildner, Thomas Hehlgans, Michael van der Wall, Reina E Mebius, Agnes Lovas, Gwendalyn J Randolph, Falk Weih, Andreas J R Habenicht.   

Abstract

OBJECTIVE: Mouse aorta smooth muscle cells (SMC) express tumor necrosis factor receptor superfamily member 1A (TNFR-1) and lymphotoxin beta-receptor (LTbetaR). Circumstantial evidence has linked the SMC LTbetaR to tertiary lymphoid organogenesis in hyperlipidemic mice. Here, we explored TNFR-1 and LTbetaR signaling in cultured SMC. METHODS AND
RESULTS: TNFR-1 signaling activated the classical RelA NF-kappaB pathway, whereas LTbetaR signaling activated the classical RelA and alternative RelB NF-kappaB pathways, and both signaling pathways synergized to enhance p100 inhibitor processing to the p52 subunit of NF-kappaB. Microarrays showed that simultaneous TNFR-1/LTbetaR activation resulted in elevated mRNA encoding leukocyte homeostatic chemokines CCL2, CCL5, CXCL1, and CX3CL1. Importantly, SMC acquired features of lymphoid tissue organizers, which control tertiary lymphoid organogenesis in autoimmune diseases through hyperinduction of CCL7, CCL9, CXCL13, CCL19, CXCL16, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1. TNFR-1/LTbetaR cross-talk resulted in augmented secretion of lymphorganogenic chemokine proteins. Supernatants of TNFR-1/LTbetaR-activated SMC markedly supported migration of splenic T cells, B cells, and macrophages/dendritic cells. Experiments with ltbr(-/-) SMC indicated that LTbetaR-RelB activation was obligatory to generate the lymphoid tissue organizer phenotype.
CONCLUSIONS: SMC may participate in the formation of tertiary lymphoid tissue in atherosclerosis by upregulation of lymphorganogenic chemokines involved in T-lymphocyte, B-lymphocyte, and macrophage/dendritic cell attraction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139367      PMCID: PMC2874749          DOI: 10.1161/ATVBAHA.109.191395

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  46 in total

Review 1.  Chemokines in vascular dysfunction and remodeling.

Authors:  Andreas Schober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-25       Impact factor: 8.311

Review 2.  Chemokines in atherosclerosis: an update.

Authors:  Alma Zernecke; Erdenechimeg Shagdarsuren; Christian Weber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

3.  Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system.

Authors:  Soumen Basak; Vincent Feng-Sheng Shih; Alexander Hoffmann
Journal:  Mol Cell Biol       Date:  2008-02-25       Impact factor: 4.272

4.  Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.

Authors:  Ralph Gareus; Elena Kotsaki; Sofia Xanthoulea; Ingeborg van der Made; Marion J J Gijbels; Rozina Kardakaris; Apostolos Polykratis; George Kollias; Menno P J de Winther; Manolis Pasparakis
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

5.  Immediate lymphotoxin beta receptor-mediated transcriptional response in host defense against L. monocytogenes.

Authors:  Stefanie Kutsch; Daniel Degrandi; Klaus Pfeffer
Journal:  Immunobiology       Date:  2007-12-31       Impact factor: 3.144

6.  Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs.

Authors:  Tomoya Katakai; Hidenori Suto; Manabu Sugai; Hiroyuki Gonda; Atsushi Togawa; Sachiko Suematsu; Yukihiko Ebisuno; Koko Katagiri; Tatsuo Kinashi; Akira Shimizu
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

7.  CXCL13 production by an established lymph node stromal cell line via lymphotoxin-beta receptor engagement involves the cooperation of multiple signaling pathways.

Authors:  Hidenori Suto; Tomoya Katakai; Manabu Sugai; Tatsuo Kinashi; Akira Shimizu
Journal:  Int Immunol       Date:  2009-02-27       Impact factor: 4.823

8.  Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves.

Authors:  Jae-Hoon Choi; Yoonkyung Do; Cheolho Cheong; Hyein Koh; Silvia B Boscardin; Yong-Seok Oh; Leonia Bozzacco; Christine Trumpfheller; Chae Gyu Park; Ralph M Steinman
Journal:  J Exp Med       Date:  2009-02-16       Impact factor: 14.307

9.  Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.

Authors:  Rolf Gräbner; Katharina Lötzer; Sandra Döpping; Markus Hildner; Dörte Radke; Michael Beer; Rainer Spanbroek; Beatrix Lippert; Catherine A Reardon; Godfrey S Getz; Yang-Xin Fu; Thomas Hehlgans; Reina E Mebius; Michael van der Wall; Dagmar Kruspe; Christoph Englert; Agnes Lovas; Desheng Hu; Gwendalyn J Randolph; Falk Weih; Andreas J R Habenicht
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

10.  Differential RelA- and RelB-dependent gene transcription in LTbetaR-stimulated mouse embryonic fibroblasts.

Authors:  Agnes Lovas; Dörte Radke; Daniela Albrecht; Z Buket Yilmaz; Ulrich Möller; Andreas J R Habenicht; Falk Weih
Journal:  BMC Genomics       Date:  2008-12-16       Impact factor: 3.969

View more
  45 in total

1.  Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression.

Authors:  Lisa A Madge; Michael J May
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

Review 3.  How dendritic cells shape atherosclerosis.

Authors:  Ekaterina K Koltsova; Klaus Ley
Journal:  Trends Immunol       Date:  2011-08-10       Impact factor: 16.687

4.  IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs.

Authors:  Francesca Barone; Saba Nayar; Joana Campos; Thomas Cloake; David R Withers; Kai-Michael Toellner; Yang Zhang; Lynette Fouser; Benjamin Fisher; Simon Bowman; Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Troy D Randall; Davide Lucchesi; Michele Bombardieri; Costantino Pitzalis; Sanjiv A Luther; Christopher D Buckley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

Review 5.  Lymphocytes and the adventitial immune response in atherosclerosis.

Authors:  Kirsti A Campbell; Michael J Lipinski; Amanda C Doran; Marcus D Skaflen; Valentin Fuster; Coleen A McNamara
Journal:  Circ Res       Date:  2012-03-16       Impact factor: 17.367

Review 6.  Stromal cell regulation of homeostatic and inflammatory lymphoid organogenesis.

Authors:  Matthew J W Kain; Benjamin M J Owens
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

7.  Effect of Pregnancy and Delivery on Cytokine Expression in a Mouse Model of Pelvic Organ Prolapse.

Authors:  Bruna M Couri; Andrew T Lenis; Ali Borazjani; Brian M Balog; Mei Kuang; Robert S Butler; Marc S Penn; Margot S Damaser
Journal:  Female Pelvic Med Reconstr Surg       Date:  2017 Nov/Dec       Impact factor: 2.091

8.  Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipients.

Authors:  S L Orloff; Y-K Hwee; C Kreklywich; T F Andoh; E Hart; P A Smith; I Messaoudi; D N Streblow
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

Review 9.  Lymphotoxin signalling in immune homeostasis and the control of microorganisms.

Authors:  Vaibhav Upadhyay; Yang-Xin Fu
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

10.  Tissue factor pathway inhibitor gene transfer prevents vascular smooth muscle cell proliferation by interfering with the MCP-3/CCR2 pathway.

Authors:  Yu Fu; Dandan Ma; Yue Liu; Hui Li; Jinyu Chi; Wenxiu Liu; Fang Lin; Jing Hu; Xiaohui Zhang; Minling Zhu; Yong Zhao; Xinhua Yin
Journal:  Lab Invest       Date:  2015-08-24       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.